These potential active compounds may regulate pathways like the MAPK signaling pathway, Lipid and Atherosclerosis, PI3K-Akt, and IL-17 signaling pathway, potentially offering anti-inflammatory effects and promoting osteocyte proliferation and differentiation. Here, IL17A is linked to atherosclerosis.